Hyponatremia is frequently associated with atypical pneumonia. One of the underlying mechanisms is inappropriate antidiuretic hormone (ADH) secretion ([@B4]). We report the first case series of coronavirus disease (COVID-19)-associated syndrome of inappropriate antidiuretic hormone secretion (SIADH). Additionally, we review pertinent literature and discuss the potential mechanism of this phenomenon.

Case 1 is a 58-yr-old man known to have well-controlled hypertension, asthma, and dyslipidemia. He presented with fever, cough, and sore throat. His sodium level was 116 mmol/L (135--145 mmol/L). The second case is a 20-yr-old man with no comorbidities; he presented with fever, cough, nausea, vomiting, lethargy, and disorientation. His sodium level was 112 mmol/L. Case 3 describes a 47-yr-old man with no comorbidities presenting with abdominal pain, fever, and a sodium level of 117 mmol/L.

The common features across the three cases were fever, evidence of pneumonia (abnormal chest X-ray depicting bilateral infiltrates), and severe hyponatremia. The workup for hyponatremia confirmed SIADH in all three cases ([Table 1](#T1){ref-type="table"}). The diagnosis was based on euvolemic hyponatremia (\< 135 mmol/L) with concurrent low serum and high urine osmolality (\< 280 and \>100 osmol/kgH~2~O, respectively) and high urine sodium (\>40 mmol/L) ([@B6], [@B15]). No underlying medication or medical conditions commonly associated with SIADH were identified. The second case was symptomatic; hence, required initial management with hypertonic saline followed by fluid restriction. The other two cases improved with fluid limitation alone. Nasopharyngeal RT-PCR confirmed COVID-19. All three cases were managed in a designated COVID-19 facility in Qatar and had a favorable outcome with the resolution of hyponatremia.

###### 

Patient summary

  Characteristics                                         *Patient 1*                                               *Patient 2*                                             *Patient 3*
  ------------------------------------------- ------------------------------------ ----------------------------------------------------------------------------- ---------------------------------
  Demography                                                                                                                                                     
      Age                                                      58                                                       20                                                      47
      Sex                                                     Male                                                     Male                                                    Male
      Nationality                                          Sri Lankan                                                Nepalese                                                 Indian
  Initial findings                                                                                                                                               
      Past medical history                     Hypertension, dyslipidemia, asthma                                 Not significant                                         Not significant
      Duration of symptoms, days                               5                                                         7                                                       3
      Symptoms                                     Fever, cough, sore throat                         Fever, cough, nausea, vomiting, lethargy                          Abdominal pain, fever
      GCS                                                    15/15                                                     12/15                                                   15/15
      Orientation                                           Oriented                                                Disoriented                                              Oriented
      Symptoms of hyponatremia                              Lethargy                                Lethargy, disorientation, nausea, agitation                                None
      Imaging features (X-ray chest)            Bilateral perihilar infiltrates     Increased bronchovascular markings initially, organized infiltrates at 72 h   Bilateral perihilar infiltrates
      Admission to ICU                                         No                                                   Yes -- 24 h                                                 No
  Laboratory findings                                                                                                                                            
      COVID-19 RT-PCR (nasopharyngeal swab)                 Positive                                                 Positive                                                Positive
      White cells, per mm^3^                                  4.6                                                       7.2                                                     4.2
  Differential                                                                                                                                                   
      Neutrophils, per mm^3^                                  2.5                                                       5.2                                                     3.2
      Lymphocytes, per mm^3^                                  0.4                                                       0.8                                                     0.7
      Eosinophils, per mm^3^                                  0.0                                                       0.0                                                     0.0
      Monocytes, per mm^3^                                    1.7                                                       1.2                                                     0.3
      Platelet count, per mm^3^                               227                                                       222                                                     110
      Hemoglobin, g/L                                          15                                                      13.5                                                     11
      CRP, mg/L                                               2.8                                                       \<5                                                     113
      Total protein, g/L                                       77                                                       76                                                      61
      Albumin, g/L                                             42                                                       34                                                      24
      Alanine aminotransferase, U/L                            13                                                       27                                                      34
      Aspartate aminotransferase, U/L                          31                                                       31                                                      39
      Glucose, mmol/L                                         5.7                                                      15.5                                                     7.8
      Urea, mmol/L                                             3                                                         5                                                      4.2
      Creatinine, μmol/L                                       74                                                       57                                                      65
      EGFR, ml·min^−^1·1.73 m^2^)                              97                                                       141                                                     110
      Serum ferritin, μg/L                                    700                                                       379                                                     900
      Potassium, mmol/L                                       3.7                                                       3.8                                                     3.8
      Chloride, mmol/L                                         77                                                       78                                                      81
      Bicarbonate, mmol/L                                      24                                                       22                                                      21
      Corrected calcium, mmol/L                               2.46                                                     2.38                                                    2.17
      Lactic acid, mmol/L                                     1.6                                                       2.4                                                     1.6
      Sodium on day 1, mmol/L                                 116                                                       112                                                     117
      Volume status                                        Euvolemic                                                 Euvolemic                                               Euvolemic
      Serum osmolality, osmol/kgH~2~O                         243                                                       253                                                     278
      Urine osmolality, osmol/kgH~2~O                         316                                                       509                                                     769
      Urine spot sodium, mmol/L                                51                                                       145                                                     71
      Diagnosis for hyponatremia                             SIADH                                                     SIADH                                                   SIADH
      Total hypertonic saline received, mL                     0                                         300 ml (3 boluses of 100ml each)                                        0
      Fluid restriction/24 h, mL                             1,200                                                      750                                                    1,000
      Serum sodium level at 24 h, mmol/L                      121                                                       120                                                     120
      Serum sodium level at 48 h, mmol/L                      122                                                       126                                                     124
      Serum sodium level at 72 h, mmol/L                      128                                                       129                                                     128
      AM serum cortisol level, nmol/L                         237                                                       523                                                Not available
      TSH level, mIU/L                                        2.22                                                      1.0                                                     2.3

COVID-19, coronavirus disease; CRP, C-reactive protein; EGFR, estimated glomerular filtration rate; GCS, Glasgow Coma Scale; ICU, intensive care unit; SIADH, syndrome of inappropriate antidiuretic hormone secretion; TSH, thyroid-stimulating hormone.

Pulmonary involvement in the form of pneumonia is prevalent among COVID-19-infected individuals as depicted by our cases, and the emerging literature ([@B3]). The mechanism of SIADH in pneumonia is not well established; however, animal models determined the role of low intravascular fluid volume and low extracellular fluid osmolality ([@B12], [@B16]). In the setting of intravascular volume depletion, baroreceptors in the carotid sinus, carotid body, and aorta activate the renin-angiotensin system. This, in turn, triggers a baroreceptor-mediated, nonosmotic ADH secretion ([@B1], [@B17]). In the case of decreased intravascular osmolality, osmoreceptors activate and increase the ADH secretion ([@B2]).

Emotional, physical, or psychological stresses and pain associated with infections (such as COVID-19) stimulate the hypothalamohypophyseal axis, leading to ADH release. Alternatively, stress activates the cortical neurons, which stimulate the hypothalamus to secrete ADH ([@B9]). Additionally, pneumonia-induced lung injury can result in a ventilation-perfusion mismatch. This mismatch results in compensatory hypoxic pulmonary vasoconstriction, leading to an inadequate filling of the left atrium. Consequent on this, a decreased left atrial stretch and increased ADH secretion occur ([@B5], [@B10]).

Marked elevation of inflammatory cytokines is described in COVID-19, leading in certain instances to cytokine storm ([@B8], [@B11], [@B14]). This increase in cytokines can result in SIADH via two mechanisms. First, inflammatory cytokines, such as IL-6, can directly stimulate the nonosmotic release of ADH ([@B13]). Second, these cytokines can injure the lung tissue and alveolar cells, which can induce SIADH via the hypoxic pulmonary vasoconstriction pathway, as previously described ([@B7]) ([Fig. 1](#F0001){ref-type="fig"}).

![Proposed mechanism for syndrome of inappropriate antidiuretic hormone secretion (SIADH) in coronavirus disease (COVID-19) infection. ADH, antidiuretic hormone secretion; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.](zh10062083710001){#F0001}

This discussion invites a study to explore the association between ADH and inflammatory cytokine levels, measured in COVID-19 patients and controls (with and without pulmonary involvement). This will advance our knowledge about the mechanism of SIADH.

There are additional clinical implications based on the aforementioned discussion. In the time of the pandemic, when medical resources are limited, any additional clue leading to the diagnosis of COVID-19 may prove valuable. Based on this limited evidence, we suggest triaging patients presenting during this pandemic with hyponatremia and fever as a high probability for COVID-19; these patients should be prioritized for testing and isolation whenever possible. A large cross-sectional study exploring the prevalence of hyponatremia and SIADH in this cohort of patients is needed to support our findings and conclusion.
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